JXN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Jackson Financial Inc (JXN) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has positive catalysts such as strong customer service recognition and hedge fund interest, the technical indicators and financial performance suggest caution. The stock lacks clear upward momentum, and recent financial results show significant challenges in profitability. Analysts are cautiously optimistic, but the stock's near-term price trend and lack of proprietary trading signals do not support immediate investment.
The MACD is below 0 and negatively expanding, indicating bearish momentum. RSI is neutral at 45.606, and moving averages are converging, showing no clear trend. The stock is trading near a pivot level of 111.997, with support at 107.925 and resistance at 116.069. Short-term price trends suggest a potential decline (-1.08% next day, -1.51% next week, -2.08% next month).
Hedge funds are significantly increasing their holdings, with a 1444.89% increase in buying activity over the last quarter.
The company has received multiple customer service awards, including 'Highest Customer Service – Financial Industry' for the 14th consecutive year, showcasing strong operational excellence.
Financial performance in Q4 2025 showed a significant net income drop (-164.37% YoY) and negative EPS (-3.14).
Technical indicators do not show bullish momentum, and the stock is likely to decline in the short term.
No recent congress trading data or proprietary trading signals to support a buy decision.
In Q4 2025, revenue increased significantly by 524.60% YoY to $1.955 billion. However, net income dropped to -$215 million (-164.37% YoY), and EPS fell to -3.14 (-170.56% YoY). Gross margin remained unchanged at 0%. The financials indicate growth in revenue but severe profitability challenges.
Analysts are cautiously optimistic. Barclays raised the price target to $137 from $128 and maintains an Overweight rating, citing strong capital strength and cash flow. Evercore ISI upgraded the stock to In Line from Underperform with a price target of $118, highlighting manageable risks but above-average tail risk. Morgan Stanley raised the price target to $105 from $101 and keeps an Equal Weight rating, expecting steady macro trends in 2026.
